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doi:10.1016/j.jmii.2010.02.001Background: Atypical bacterial pathogensdincluding Mycoplasma pneumoniae, Chlamydophi-
la pneumoniae, and Chlamydia trachomatisdare important infectious agents of the respira-
tory system. Most current information pertains to adults and little is known about the role
of these organisms in lower respiratory tract infections among young children with acute
bronchiolitis.
Methods: This study detected these pathogens in the nasopharyngeal secretions of children
between 1 month and 2 years of age admitted with acute bronchiolitis to hospitals in Khon
Kaen, northeast Thailand. The M pneumoniae and C pneumoniae in the nasopharyngeal secre-
tions were detected using multiplex and nested-polymerase chain reaction (PCR), whereas PCR
and restriction fragment length polymorphism were used to investigate C trachomatis. These
samples were also tested by multiplex reverse transcriptase PCR for respiratory viruses,
including respiratory syncytial virus (RSV), influenza A, influenza B, and human metapneumo-
virus.
Results: Of the 170 samples taken from hospitalized children with acute bronchiolitis, 12.9%
were infected with atypical bacteria and 85.3% with respiratory viruses. RSV was the most
common causative viral agents found in 64.7% of the samples. M pneumoniae was the most
common atypical bacterial pathogen (14/170, 8.2%) and most of the patients infected with
it were between 6 and less than 12 months of age (71 cases). Of the infected cases in this
age group, 7 of 14 were infected with M pneumoniae and 4 of 4 with C pneumoniae. Botht of Microbiology, Faculty of Medicine, Khon Kaen University, Ambhur Muang, Khon Kaen 40002,
(C. Pientong).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
96 C. Pientong et al.M pneumoniae (13/14) and C pneumoniae (4/4) had etiologies indicating viral coinfections.
Four (2.4%) of all of the cases had C trachomatis infections and all of these were infected with
RSV, including three patients less than 6 months of age.
Conclusion: These results suggest that in children with virus-induced acute bronchiolitis coin-
fection with M pneumoniae, C pneumoniae, or C trachomatis can be expressed differently in
each age group. These atypical bacteria may be the important infectious agents that induce
severe illness of acute bronchiolitis.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Acute bronchiolitis is the most common lower respiratory
tract infection and the most frequent cause of hospitali-
zation in young children. The most common pathogen is
respiratory syncytial virus (RSV), which occurs as a yearly
winter epidemic with various symptoms, ranging from mild
upper respiratory tract infection to severe bronchiolitis
with hyperinflated lungs and hypoxemia.1
The atypical bacterial pathogensdMycoplasma pneu-
moniae, Chlamydophila pneumoniae, and Chlamydia tra-
chomatisdare recognized as respiratory pathogens. They
are all small bacteria and cannot be detected using routine
culturing methods.
M pneumoniae is a well-known childhood pathogen and
is highly transmissible. Most infections caused by this
organism are relatively minor (including pharyngitis, tra-
cheobronchitis, bronchiolitis, and croup) with one-fifth
being asymptomatic. Acute infections with this organism
may promote the exacerbation of asthmatic symptoms and
may be accompanied by wheezing in children not having
asthma.2
C pneumoniae was also reported in acute lower respi-
ratory infection with mild dyspnea and wheezing in the
pediatric population.3 Acute C pneumoniae infections have
been associated with the presence and/or exacerbation of
asthma in children.4
C trachomatis is transmitted by infected women to their
infants at birth via contact with infected cervicovaginal
secretion. If the infection is not detected and treated, such
infected infants may develop conjunctivitis, bronchiolitis,
and pneumonia.5 It should therefore not be ruled out in
infants less than 6 months of age with clinical symptoms of
lower respiratory tract disease for which no other pathogen
can be found.
One of the main difficulties in dealing with lower respi-
ratory tract infections in pediatric patients is correctly
identifying the infecting agent. Culture, antigen screening,
and serological methods are only helpful in about one of
three cases.6 Chlamydia and mycoplasma are common
bacteria that may cause rhinitis, pharyngitis, bronchitis,
and pneumonia,7 and bronchiolitis may predispose some
infants to developing childhood asthma or asthma exacer-
bation. Despite their ubiquity, chlamydia and mycoplasma
are among the least frequently diagnosed respiratory
pathogens in the clinical setting mainly because of the lack
of standardized, rapid, and specific diagnostic tests.8
Chlamydia and mycoplasma are fastidious and difficult
to grow in culture, so they require either specialized cellculture techniques or a long period of incubation before
their presence can be confirmed or excluded. The inter-
pretation of serological tests used for C pneumoniae,
C trachomatis, and M pneumoniae diagnoses is also prob-
lematic because a large proportion of the population has
preexisting IgG antibodies from prior exposure(s)9; there-
fore, diagnosis of infections caused by these organisms is
usually confirmed with the polymerase chain reaction (PCR)
technique.
To our knowledge, there are few reports about atypical
bacterial pathogen infection in children with acute bron-
chiolitis, especially in northeast Thailand. We, therefore,
conducted our study using a PCR technique to estimate the
prevalence of C pneumoniae, C trachomatis, and M pneu-
moniae infections in pediatric patients with acute bron-
chiolitis admitted to either of two hospitals in Khon Kaen
province, Thailand.
Methods
Subjects and sample collection
This study was approved by the Khon Kaen University Ethics
Committee for Human Research, as per the Helsinki
Declaration. This study was part of a randomized, clinical
trial evaluating the efficacy of dexamethasone for the
treatment of acute bronchiolitis (registered in
ClinicalTrials.gov identification number: NCT00122785).
Between April 2002 and August 2004, children with acute
bronchiolitis hospitalized at either of two hospitals in Khon
Kaen, northeast Thailand, were recruited with informed,
written, parental consent. Acute bronchiolitis was defined as
the first episode of wheezing associated with tachypnea,
increased respiratory effort, and an upper respiratory tract
infection. Patients were eligible for the study if theymet the
following criteria: being between 4 weeks and 24 months of
age and being admitted with their first episode of wheezing
within 7 days. Patients were excluded from the study if they
had (1) a known history of asthma; (2) a previous history of
intubation; (3) a history of bronchopulmonary dysplasia or
chronic lung disease; (4) an underlying congenital heart
disease or any immunodeficiency; or (5) been on any steroid
treatment within the previous 2 weeks.
On admission, a sample of nasopharyngeal secretion was
taken from each child’s nostril by a previously described
technique.10 The secretion obtained was immediately put
into a tube containing viral transport media and then was
sent to a laboratory for processing. Aliquots of samples
were stored at 70C until used.
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DNA extraction
DNA was extracted from a 200-mL aliquot of sample using
a PUREGENE DNA purification kit (Gentra Systems, Minne-
apolis, MN, USA) as per the manufacturer’s instructions.
The integrity of the DNA was confirmed by amplification of
a housekeeping gene (b-globin) from the DNA samples,
using the PC04/GH20 primers (Invitrogen Life Technologies,
Carlsbad, CA, USA).
Multiplex and nested PCRs for detection ofM pneumoniae
and C pneumoniae
Multiplex PCR was used for simultaneous detection of M
pneumoniae and C pneumoniae. The chosen primers of M
pneumoniae enclosed a specific 144 bp fragment: MP5-1 (50-
GAA GCT TAT GGT ACA GGT TGG-30) and MP5-2 (50-ATT ACC
ATC CTT GTT GTA AGG-30).11 The primers for C pneumo-
niadspecific for the Omp1 genedwere: Cpn1 (50-GTT CAA
TCT CGT TGG TTT ATT-30, nt 453e473) and Cpn3 (50-TCC
AAT GTA TGG CAC TAA AGA-30, nt 858e838, 405 bp).12
Every sample with a negative result using multiplex PCR
was reanalyzed using specific nested PCRs under the same
conditions to differentiate between the two pathogens.
The specific nested PCRs were performed in parallel with
the primers Cpn1 and Cpn2 (50-ATT GAT GGT CGC AGA CTT
TGT T-30, 339 bp) for C pneumoniae12 and primers MUH-1
and MUH-2 (104 bp)13 for M pneumoniae. All of the ampli-
fication products were analyzed using 2% (wt/vol) agarose
gel electrophoresis followed by ethidium bromide staining.
A no-template negative control and a low-concentration of
each of M pneumoniae or C pneumoniae DNA positive
control were done with each run.
PCR and restriction fragment length polymorphism
analysis for detection of C trachomatis
Primers corresponding to the Omp2 gene (i.e. Ch1: 50-ATG
TCC AAA CTC ATC AGA CGA G-30 and Ch2: 50-CCT TCT TTA
AGA GGT TTT ACC CA-30 were used. Standard amplification
conditions for the primers Ch1 and Ch2 were used.14 Each
PCR product (603 bp) was separated on 1.5% agarose gel and
was then investigated with restriction fragment length
polymorphism using restriction enzyme Alu I (Promega,Table 1 Baseline demographic data of the study population
Demographic data Total (nZ 170)
Age (mo) 10.7 5.7
Sex, male 107 (62.9)
Breastfeeding 160 (94.1)
Atopic historydparents 49 (28.8)
Passive smoker 102 (60)
Fever before admission 155 (91.2)
Clinical scorea 7.1 1.4 (5e11)
O2 saturation< 95% at enrollment 83 (48.8)
a Modified from De Boeck et al.16 and Tal et al.17
Data are presented as mean standard deviation, n(%) or mean sta
The clinical score is based on four respiratory variables and is scored u
(0e3 points), cyanosis (0e3 points), and accessory muscle use (0e3 p
RSVZ respiratory syncytial virus.Madison, WI, USA). Digestion was performed by incubating
10 mL of PCR product with 1 U of enzyme, 2 mL of 10 buffer,
and 7 mL of water for 1 hour at 37C. The PCR products were
analyzed using electrophoresis on a 4% agarose gel, stained
with ethidium bromide, and compared with the predicted
fragments. For C trachomatis, the fragment lengths of 158,
119 and 114, and 84 and 77 bp were accurately predicted.
Virus study
RNA extraction
An aliquot of the same samples was also detected for
respiratory viruses, including RSV, influenza A, influenza B,
and human metapneumovirus (hMPV). The RNA was
extracted from 140 mL of nasopharyngeal secretion using
a QIAamp viral RNA mini kit (Qiagen, Germany).
Multiplex reverse transcriptase PCR
The extracted RNA was tested for RSV, influenza A, influenza
B, and hMPV using multiplex reverse transcriptase (RT)-PCR
as described by Bellau-Pujol et al.15 Briefly, 5 mL of RNA was
added to 20-mL reaction mixtures of the one-step RT-PCR kit
(Qiagen, Germany) and 0.4 mM of each of viral-specific
forward and reverse primers. cDNAs of the virusesdprovided
by Professor Dr. Franc¸ois Freymuth (Caen University
Hospital, France)dwere used as the positive controls. Then,
the one-step RT-PCR products (2 mL) were subjected to
heminested multiplex PCR, performed in a 25-mL volume
containing 10 buffer (New England Biolabs, Ipswich, MA,
USA), 0.2 mM dNTPs, another set of primers, and 1 U of Taq
DNA polymerase (New England Biolabs).
Results
During the study period, 170 children were diagnosed with
acute bronchiolitis needing hospitalization; their parents
gave consent and so the children were eligible for collection
of nasopharyngeal secretions, whichwere used for detection
of atypical bacteria, including M pneumoniae, C pneumo-
niae, and C trachomatis, as well as detection of respiratory
viruses, such as RSV, influenza A, influenza B, and hMPV.
The baseline demographic data of all children and
subgroups are presented in Table 1. The mean age wasRSV (nZ 110) Bacteria (nZ 22) Student
t test (p)
10.2 5.7 9.8 5.8 0.000
65 (59.1) 15 (68.2) 0.215
102 (92.7) 21 (95.4) 0.323
34 (30.9) 6 (27.3) 0.369
63 (57.3) 19 (86.4) 0.005
99 (90.0) 20 (90.9) 0.450
7.0 1.4 (5e11) 7.2 1.1 (5e9) 0.000
57 (51.8) 14 (63.6) 0.157
ndard deviation (range).
sing the following scales: respiratory rate (0e3 points), wheezing
oints).
Table 2 Clinical manifestations of C trachomatis infants
Clinical manifestations Infant I Infant II Infant III Infant IV
Age (mo) 1.7 1.7 2.5 23.5
Sex Male Male Male Female
Atopic history No No Yes Yes
Clinical score at enrollmenta 6 6 7 8
O2 saturation at enrollment (%) 92 95 99 93
Symptoms before enrollment (d) 5 7 3 4
Respiratory distress before enrollment (hr) 48 168 12 48
a Modified from De Boeck et al.16 and Tal et al.17
C trachomatisZ Chlamydia trachomatis.
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severe respiratory distress at admission. In cases of acute
bronchiolitis, respiratory viruses were found in 85.3% (145/
170) of the cases, whereas atypical bacteria (i.e. M pneu-
moniae, C pneumoniae, and C trachomatis) were found in
12.9% of the cases (22/170). Of the respiratory viruses, RSV
was the most common etiologic organism (64.7%) followed
by influenza A (12.9%), influenza B (4.1%), and hMPV (3.5%).
Of the 22 children in whom atypical bacterial etiologies
were detected, four were infected with C trachoma-
tisdthe clinical characteristics of which are presented in
Table 2. All of these children had moderate respiratory
distress at admission.
According to age, the children with acute bronchiolitis
were separated into three groups (Table 3). Children
between 6 and less than 12 months of age had the highest
incidence (41.8%). In our study, M pneumoniae was the
most common causal organism found (8.2%, 14/170 cases)
among the bacterial pathogens and most frequently in
children older than 6 months of age. C pneumoniae was
detected in four cases of acute bronchiolitis (2.4%) all of
whom were between 6 and less than 12 months of age. Four
cases of acute bronchiolitis (2.4%) were positive for C tra-
chomatis, which was the most frequent cause in children
between 1 and less than 6 months of age.
Twenty cases of the atypical bacterial bronchiolitis had
coinfection with viral respiratory pathogen (Table 4).
Indeed, almost all of the M pneumoniae (13/14) and C
pneumoniae (3/4) cases were coinfected with viral respi-
ratory pathogens. Coinfection with RSV was the most
frequent. All cases of positive C trachomatis infection were
detected in patients infected with RSV.Discussion
Recent evidence indicates that infections by intracellular
pathogens, such as chlamydia and mycoplasma, may causeTable 3 Atypical bacterial infection in 170 nasopharyngeal sam
Age group (mo) n M pneumoniae
1 to <6 36 2
6 to <12 71 7
12e24 63 5
Total 170 14 (8.2%)
C trachomatisZ Chlamydia trachomatis; C pneumoniaeZ Chlamydoacute and chronic wheezing in some individuals. The highest
percentage of the serum samples positive forMpneumoniae-
specific antibodies occurred in patients with asthma (60%),
a full two-fold greater than in the control subjects. Specific
anti-C pneumoniae antibodies were also observed but in
a smaller percentage (i.e. 13.3% of children with asthma).18
Using PCR, Freymuth et al.4 detected M pneumoniae and C
pneumoniae in 8% of 132 children with acute exacerbation of
asthma. Recently, Biscardi et al.19 found M pneumoniae
infection in 20% and C pneumoniae infection in 3.4% of 119
children hospitalized for severe asthma.
We were therefore interested in the infection of these
atypical bacteria in acute bronchiolitis because bronchio-
litis may especially predispose some infants to develop
childhood asthma or asthma exacerbation. Hence, we
investigated the prevalence of M pneumoniae and chla-
mydia (including C pneumoniae and C trachomatis) using
PCR-based techniques to highlight the role of these organ-
isms in respiratory tract infections, especially in children
with acute bronchiolitis.
All 170 samples of children, hospitalized for acute
bronchiolitis, were evaluated in this study conducted in
Khon Kaen province, northeast Thailand. The nasopharyn-
geal secretion was sampled at the time of admission. Two-
thirds (145/170) of the children had viral etiologies,
including RSV, influenza virus, and hMPV. The association of
hMPV and RSV in children younger than 2 years of age with
acute bronchiolitis was previously reported.10 After using
atypical bacterial pathogen detection techniques, M
pneumoniae infection was found in 8.2% of the patients,
whereas acute C pneumoniae infection was found in 2.4%;
both occurred mostly in children between 6 and less than 12
months of age (Table 3).
Ouchi et al.20 evaluated 1,104 Japanese children with
acute lower respiratory tract infections; and of these, 149
(13.5%) had acute C pneumoniae infections, 118 (10.7%)
had acute M pneumoniae infections, and 27 (2.4%) had
both. M pneumoniae was more common than C pneumoniaeples of children with acute bronchiolitis




4 (2.4%) 4 (2.4%)
phila pneumoniae; M pneumoniaeZMycoplasma pneumoniae.
Table 4 Coinfection by atypical bacterial pathogen with viral respiratory pathogens in children with acute bronchiolitis
Pathogens RSV Influenza A Influenza B hMPV RSV and influenza A Total, n (%)
M pneumoniae (14 cases) 6 2 2 2 1 13 (92.9)
C pneumoniae (4 cases) 3 0 0 0 0 3 (75)
C trachomatis (4 cases) 4 0 0 0 0 4 (100)
C trachomatisZ Chlamydia trachomatis; C pneumoniaeZ Chlamydophila pneumoniae; hMPVZ human metapneumovirus;
M pneumoniaeZMycoplasma pneumoniae; RSVZ respiratory syncytial virus.
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was more common in patients with bronchitis. C pneumo-
niae was more common among younger children and in
those who presented with wheezing.
In an Argentinean study, 49 of 255 (19.2%) children
between 1 and 18 months of agedwithout evidence of viral
or bacterial infections but with clinical and radiological
evidence of acute lower respiratory distressdwere tested
serologically for a recent C trachomatis infection. The
results were positive in 28 of 166 (16.9%) children with
bronchiolitis and in 18 of 89 (20.2%) with pneumonia.
C trachomatis infection was detected in all age groups up
to 18 months. Thirty of 49 infections were in children older
than 3 months of age and 16 in children older than 6
months. These results suggest that C trachomatis infection
may be associated with bronchiolitis and pneumonia in
children between the 1 and 18 months of age, a proportion
of which may be horizontally transmitted.21,22
In our study, C trachomatis infection was detected in
only 2.35% because most of the C trachomatis cases (3/4
cases) were found in children less than 6 months of age
(Table 3). It was found in only one case of a child between
12 and 24 months of age. This difference may depend on
the method of determination; however, our study corre-
sponds to a study in Turkey by Bu¨tu¨n et al.23 who reported
that 3% of C trachomatis infections in 100 children between
3 months and 12 years of age were admitted to the pedi-
atric outpatient department with respiratory symptoms,
such as fever, cough, and respiratory distress.
Coinfection by viruses and bacteria in the respiratory
airways is common although their role in the outcome of
illness is controverted.24,25 Notwithstanding, individual
infectious agents have been associated with the develop-
ment of chronic lung disease and exacerbation of
asthma.26e29 Coinfection of two atypical bacterial
agentsdpossessing chronic sequelae potentialdmay result
in a protracted illness,30 more severe illness, and/or a poor
long-term outcome. In our study, all of the cases of C tra-
chomatis infectionwere coinfectedwith RSV.Mpneumoniae
and C pneumoniae were also detected in coinfection with
viral etiologies, especially RSV (Table 4). The range mean
(standard deviation) of clinical scores between atypical
bacterial infected cases (severe) and RSV-induced bron-
chiolitis (moderate) were statistically different. Their clin-
ical manifestations, however, were not different (Tables 1
and 2) as all of the children had moderate to severe respi-
ratory distress on admission.
Bacterial coinfections occurring in respiratory viral
infections were reported by Lehtinen et al.31 who studied
the phenomenon in a total of 220 children with viral
wheezing between 3 months and 16 years of age. Rhinovirus(32%), RSV (31%), and enteroviruses (31%) were the most
common causative viruses. Serologic evidence of bacterial
coinfection was found in 18% of the children, in whom
Streptococcus pneumoniae (8%) and M pneumoniae (5%)
infection were the most common. In contrast, Esposito
et al.32 used serologic investigative techniques and PCR to
demonstrate M pneumoniae in 22.5% and C pneumoniae in
15.5% of children with acute wheezing compared with 7.5%
and 2.5%, respectively, in healthy control subjects. When
the children who were infected with either organism were
treated with clarithromycin, improvement in the course of
disease was observed, which supports the hypothesis that
these atypical organisms exacerbate asthma. Biscardi
et al.19, however, found M pneumoniae infection in 20% and
C pneumoniae infection in 3.4% of 119 children hospitalized
for severe asthma, and the benefits of antibiotic treatment
were questionable. In our study, the number of atypical
bacterial infections was small because it resulted from
a limited number of patients with acute childhood bron-
chiolitis. This limitation may therefore affect the differ-
ence in their clinical manifestations.
In conclusion, our study indicates that atypical bacteria
are being detected as coinfections in children with viral-
induced bronchiolitis or wheezing, which varies according
to age group. These results suggest that the atypical
bacteria may be important coinfection agents of respira-
tory viruses, which may induce severe illness of acute
childhood bronchiolitis. Further investigation may be war-
ranted, especially of more severe cases.
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